Growth Metrics

Femasys (FEMY) Current Leases (2020 - 2026)

Femasys posted quarterly Current Leases of $480286.0 for Q1 2026, down 5.86% year-on-year from $510171.0 in Q1 2025, and down 1.5% on a QoQ basis from $487624.0 in Q4 2025.

Femasys (FEMY) has 7 years of Current Leases data on file, last reported at $480286.0 in Q1 2026.

  • For the quarter ending Q1 2026, Current Leases fell 5.86% year-over-year to $480286.0; the trailing twelve-month figure through Mar 2026 stood at $480286.0 (down 5.86% YoY), and the FY2025 full-year result was $487624.0, down 5.86% from the prior year.
  • Current Leases for Q1 2026 stood at $480286.0, down from $487624.0 in the prior quarter.
  • Across five years, Current Leases topped out at $533734.0 in Q2 2024 and bottomed at $209098.0 in Q2 2023.
  • The 5-year median for Current Leases is $480286.0 (2026), against an average of $437297.5.
  • The widest annual swing landed in 2023, when Current Leases slumped 47.0%; it then surged 155.26% in 2024.
  • A 5-year view of Current Leases shows it stood at $373833.0 in 2022, then climbed by 8.77% to $406636.0 in 2023, then grew by 27.38% to $517967.0 in 2024, then fell by 5.86% to $487624.0 in 2025, then declined by 1.5% to $480286.0 in 2026.
  • The last three Current Leases figures came in at $480286.0 (Q1 2026), $487624.0 (Q4 2025), and $494954.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn -
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn -
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 29.23 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 21.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn -
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn -
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn -
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn -
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn -
10 Femasys 22.30 Mn 16.91 Mn - 480,286.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 480,286.00
Dec 31, 2025 487,624.00
Sep 30, 2025 494,954.00
Jun 30, 2025 502,468.00
Mar 31, 2025 510,171.00
Dec 31, 2024 517,967.00
Sep 30, 2024 525,752.00
Jun 30, 2024 533,734.00
Mar 31, 2024 494,967.00
Dec 31, 2023 406,636.00
Sep 30, 2023 410,219.00
Jun 30, 2023 209,098.00
Mar 31, 2023 305,071.00
Dec 31, 2022 373,833.00
Sep 30, 2022 386,139.00
Jun 30, 2022 394,518.00
Mar 31, 2022 400,620.00
Dec 31, 2021 406,674.00
Sep 30, 2021 412,911.00
Jun 30, 2021 419,333.00
Dec 31, 2020 434,072.00